These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 36819240)

  • 1. LI-RADS LR-5 on contrast-enhanced ultrasonography has satisfactory diagnostic specificity for hepatocellular carcinoma: a systematic review and meta-analysis.
    Jin H; Cai Y; Zhang M; Huang L; Bao W; Hu Q; Chen X; Zhou L; Ling W
    Quant Imaging Med Surg; 2023 Feb; 13(2):957-969. PubMed ID: 36819240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compared with SonoVue
    Cao J; Wang H; Ling W
    Quant Imaging Med Surg; 2024 Apr; 14(4):2978-2992. PubMed ID: 38617150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of modified contrast-enhanced ultrasound Liver Imaging Reporting and Data System (CEUS LI-RADS) using Sonazoid in diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis.
    Liu Q; Liu T; Liu X; Zhang F; Yang J; Cheng Y; Yang Q
    Quant Imaging Med Surg; 2024 Apr; 14(4):2927-2937. PubMed ID: 38617149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compared with CT/MRI LI-RADS, whether CEUS LI-RADS is worth popularizing in diagnosis of hepatocellular carcinoma?-a direct head-to-head meta-analysis.
    Wang H; Cao J; Fan H; Huang J; Zhang H; Ling W
    Quant Imaging Med Surg; 2023 Aug; 13(8):4919-4932. PubMed ID: 37581040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic Accuracy of CEUS LI-RADS for the Characterization of Liver Nodules 20 mm or Smaller in Patients at Risk for Hepatocellular Carcinoma.
    Huang JY; Li JW; Lu Q; Luo Y; Lin L; Shi YJ; Li T; Liu JB; Lyshchik A
    Radiology; 2020 Feb; 294(2):329-339. PubMed ID: 31793849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The American College of Radiology contrast-enhanced ultrasound Liver Imaging Reporting and Data System and its modified version in diagnosing hepatocellular carcinoma via Sonazoid: a meta-analysis.
    Cao J; Wang H; Ruan X; Yang J; Ren Y; Ling W
    Quant Imaging Med Surg; 2024 Jul; 14(7):4555-4566. PubMed ID: 39022290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy of contrast-enhanced ultrasound liver imaging reporting and data system: a systematic review and meta-analysis.
    Son JH; Choi SH; Kim SY; Lee SJ; Park SH; Kim KW; Won HJ; Shin YM; Kim PN
    Hepatol Int; 2020 Dec; 14(6):1104-1113. PubMed ID: 33170416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast-enhanced ultrasound liver imaging reporting and data system for diagnosing hepatocellular carcinoma: A meta-analysis.
    Shin J; Lee S; Bae H; Chung YE; Choi JY; Huh YM; Park MS
    Liver Int; 2020 Oct; 40(10):2345-2352. PubMed ID: 32722894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MR versus CEUS LI-RADS for Distinguishing Hepatocellular Carcinoma from other Hepatic Malignancies in High-Risk Patients.
    Huang Z; Zhou P; Li S; Li K
    Ultrasound Med Biol; 2021 May; 47(5):1244-1252. PubMed ID: 33610338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic efficacy of contrast-enhanced ultrasound versus MRI Liver Imaging Reporting and Data System (LI-RADS) for categorising hepatic observations in patients at risk of hepatocellular carcinoma.
    Li S; Zhou L; Chen R; Chen Y; Niu Z; Qian L; Fang Y; Xu L; Xu H; Zhang L
    Clin Radiol; 2021 Feb; 76(2):161.e1-161.e10. PubMed ID: 33198943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic accuracy of contrast-enhanced ultrasound for the differential diagnosis of hepatocellular carcinoma: ESCULAP versus CEUS-LI-RADS.
    Schellhaas B; Görtz RS; Pfeifer L; Kielisch C; Neurath MF; Strobel D
    Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1036-1044. PubMed ID: 28562394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic performance of LI-RADS for MRI and CT detection of HCC: A systematic review and diagnostic meta-analysis.
    Liang Y; Xu F; Guo Y; Lai L; Jiang X; Wei X; Wu H; Wang J
    Eur J Radiol; 2021 Jan; 134():109404. PubMed ID: 33276248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of CEUS LI-RADS for the Accurate Diagnosis of Nodules in Patients at Risk for Hepatocellular Carcinoma: A Validation Study.
    Makoyeva A; Kim TK; Jang HJ; Medellin A; Wilson SR
    Radiol Imaging Cancer; 2020 Mar; 2(2):e190014. PubMed ID: 33778701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk stratification for hepatocellular carcinoma of contrast-enhanced ultrasound Liver Imaging Reporting and Data System (LI-RADS) and the diagnostic performance of LR-5 and LR-M: a systematic review and meta-analysis.
    Qin Z; Zhou Y; Ding J; Wen J; Chen Y; Zhou H; Jing X
    Clin Radiol; 2022 Apr; 77(4):e280-e286. PubMed ID: 35164930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic Performance of CT/MRI Liver Imaging Reporting and Data System v2017 for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
    Lee S; Kim SS; Roh YH; Choi JY; Park MS; Kim MJ
    Liver Int; 2020 Jun; 40(6):1488-1497. PubMed ID: 32145134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast-enhanced ultrasound LI-RADS 2017: comparison with CT/MRI LI-RADS.
    Ding J; Long L; Zhang X; Chen C; Zhou H; Zhou Y; Wang Y; Jing X; Ye Z; Wang F
    Eur Radiol; 2021 Feb; 31(2):847-854. PubMed ID: 32803416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance for malignant progression of LI-RADS version 2017 category 3/4 nodules using contrast-enhanced ultrasound.
    Huang H; Li CQ; He DN; Ruan SM; Li MD; Cheng MQ; Lu MD; Kuang M; Wang W; Wang Y; Chen LD
    Eur Radiol; 2023 Dec; 33(12):9336-9346. PubMed ID: 37405501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Performance of Contrast-enhanced Ultrasound Liver Imaging Reporting and Data System LR-5 in the Diagnosis of Hepatocellular Carcinoma:A Meta-analysis].
    Yan XY; Lü K; Chen TJ; Li JC
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Feb; 45(1):57-63. PubMed ID: 36861156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between CEUS LI-RADS categorization of HCC < 20 mm and clinic-pathological features.
    Yang D; Chen X; Huang L; Wang X; Mao L; Lin L; Han H; Lu Q
    Insights Imaging; 2024 May; 15(1):110. PubMed ID: 38713251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Value of CEUS LI-RADS combined with AFP in early diagnosis of hepatocellular carcinoma in low- and high-risk patients.
    Wu Y; Chen Y; Wei L; Ding Z; Zhao S; Bao S; Tang J; Li H; Liu J; Zhu S
    J Cancer Res Ther; 2024 Aug; 20(4):1274-1283. PubMed ID: 38958652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.